| Objective Studies have shown that the incidence of pulmonary embolism increased significantly in recent years,but not as good as or improper treatment may make pulmonary embolism mortality among patients,a substantial increase in the pulmonary embolism has become the third largest cause of death in disease of heart head blood-vessel.And the European society of cardiology advocate the low-risk group pulmonary embolism to reduce the length of time.Domestic and international studies in recent years have shown that risk stratification of pulmonary embolism is beneficial in guiding the treatment of patients,and that outpatient treatment of pulmonary embolism in the low-risk group can reduce the rate of hospitalization of patients.Clinical studies on low-and intermediate-risk pulmonary embolism in China are rare.In this paper,we investigated the differences in clinical manifestations,platelets,hemoglobin,cardiac function,and lower extremity venous thrombosis between low-and intermediate-risk patients using the sPESI score to understand the differences between the two groups under this classification.we try to provide a theoretical basis and guidance for clinical guidance on the diagnosis and treatment of pulmonary embolism and the adoption of reasonable and effective examination and treatment measures.Timely identification of pulmonary embolism severity increases,take early intervention to avoid disease continue to develop,to guide the clinical treatment,reduction of pulmonary embolism mortality to provide the reference.Methods In strict accordance with the inclusion and exclusion criteria,209 patients diagnosed as pulmonary embolism by PTCA in the First and Second Affiliated Hospital of Anmedical University from January 2019 to January 2022 were selected as the research objects,and the clinical data of the patients were retrospectively analyzed.The information included: 1.General information: gender,age,history of coronary heart disease,hypertension and diabetes;2.Clinical symptoms: main symptoms,pulse,arterial systolic pressure,etc.3.Laboratory and imaging examination: red blood cell count(RBC),hemoglobin(Hb),plasma D-dimer(D-D),fibrinogen(FIB),etc.,4.Treatment methods: surgery,anticoagulation,thrombolysis,etc.SPSS 26.0 software was used to analyze the data between the two groups.Results There were significant differences between the two groups in age,heart rate,hemoglobin concentration,red blood cell count,prothrombin activity,and D-dimer indicators.In terms of age,the intermediate-risk group was significantly higher than the low-risk group(P < 0.05).The heart rate of the moderate risk group was significantly higher than that of the low risk group(P < 0.05).The hemoglobin concentration in the low-risk group was significantly higher than that in the medium-risk group(P < 0.05).The red blood cell count in the low-risk group was significantly higher than that in the medium-risk group(P < 0.05).The prothrombin activity index in the low-risk group was significantly higher than that in the medium-risk group(P < 0.05).D-dimer index in the intermediate-risk group was significantly higher than that in the low-risk group(P < 0.05).There was no significant difference in clinical symptoms between the moderate risk group and the low risk group(P > 0.05).The results of linear regression analysis showed that age and heart rate,and hemoglobin were the independent high risk factors affecting the risk stratification of pulmonary embolism patients.Conclusion There is few differences in clinical symptoms between the low-risk and intermediate-risk pulmonary embolism groups,so it is difficult to distinguish low-risk and intermediate-risk pulmonary embolism by using reliable clinical manifestations in clinical diagnosis and treatment.Combined with patient’s age,heart rate and hemoglobin content,prothrombin activity,D-dimer level,you can assess whether the severity of disease increases further,for the clinical diagnosis and treatment of pulmonary embolism patients provide the beneficial reference. |
PDF Full Text Request